Aprogen Medicines Inc. (KRX: 007460)
South Korea
· Delayed Price · Currency is KRW
800.00
-16.00 (-1.96%)
Dec 20, 2024, 3:30 PM KST
Aprogen Medicines Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | -42,270 | -55,619 | -98,657 | -93,920 | -46,490 | -10,839 | Upgrade
|
Depreciation & Amortization | 29,071 | 29,071 | 28,392 | 25,262 | 4,308 | 3,251 | Upgrade
|
Loss (Gain) From Sale of Assets | -30.3 | -30.3 | 457.39 | - | 3.45 | 2.78 | Upgrade
|
Asset Writedown & Restructuring Costs | 2,271 | 2,271 | 9,162 | 223.61 | 241.5 | 511.53 | Upgrade
|
Loss (Gain) From Sale of Investments | -341.93 | -341.93 | 2,744 | 1,228 | 1,825 | 431.74 | Upgrade
|
Loss (Gain) on Equity Investments | - | - | 1,489 | 9,543 | 9,780 | 20,714 | Upgrade
|
Stock-Based Compensation | 1,613 | 1,613 | 707.67 | 2,445 | - | - | Upgrade
|
Provision & Write-off of Bad Debts | -8.5 | -8.5 | -5,001 | - | -74.85 | -1,750 | Upgrade
|
Other Operating Activities | -31,772 | -19,249 | -35,587 | -17,926 | 51,030 | -4,792 | Upgrade
|
Change in Accounts Receivable | 1,749 | 1,749 | 3,395 | 778.84 | 4,177 | -830.06 | Upgrade
|
Change in Inventory | -5,024 | -5,024 | -17,526 | -8,367 | 41.12 | -3,770 | Upgrade
|
Change in Accounts Payable | -1,075 | -1,075 | -1,852 | 3,378 | -28.79 | -154.73 | Upgrade
|
Change in Unearned Revenue | - | - | - | - | -166.97 | -1,123 | Upgrade
|
Change in Income Taxes | 217.8 | 217.8 | 935.78 | 770.88 | 378.18 | -442.85 | Upgrade
|
Change in Other Net Operating Assets | -5,470 | -11,731 | -2,151 | -8,155 | -2,491 | -2,325 | Upgrade
|
Operating Cash Flow | -51,068 | -58,156 | -113,491 | -84,740 | 22,534 | -1,116 | Upgrade
|
Capital Expenditures | -10,808 | -25,514 | -19,610 | -34,392 | -2,576 | -7,853 | Upgrade
|
Sale of Property, Plant & Equipment | 37.31 | 2,273 | 131.65 | 40.06 | 54.15 | 2,802 | Upgrade
|
Cash Acquisitions | - | - | 39,940 | - | - | 18,135 | Upgrade
|
Divestitures | - | - | 29,285 | - | - | - | Upgrade
|
Sale (Purchase) of Intangibles | -16,652 | -29,371 | -5,209 | -474.06 | -391.26 | -323.8 | Upgrade
|
Investment in Securities | 6,071 | 965.68 | 27,268 | 18,390 | -19,407 | 99,366 | Upgrade
|
Other Investing Activities | -11,361 | 8,193 | -1,690 | -924.3 | -61,133 | -204,004 | Upgrade
|
Investing Cash Flow | -32,713 | -43,452 | 70,172 | -12,790 | -168,494 | -151,413 | Upgrade
|
Short-Term Debt Issued | - | 14,610 | 96,500 | 134,190 | - | - | Upgrade
|
Long-Term Debt Issued | - | 96,546 | - | 30,845 | 70,000 | 70,000 | Upgrade
|
Total Debt Issued | 62,775 | 111,156 | 96,500 | 165,035 | 70,000 | 70,000 | Upgrade
|
Short-Term Debt Repaid | - | -40,110 | -7,500 | -27,000 | - | -6,000 | Upgrade
|
Long-Term Debt Repaid | - | -8,481 | -1,873 | -30,220 | -643.93 | -3,651 | Upgrade
|
Total Debt Repaid | -39,561 | -48,591 | -9,373 | -57,220 | -643.93 | -9,651 | Upgrade
|
Net Debt Issued (Repaid) | 23,214 | 62,565 | 87,127 | 107,815 | 69,356 | 60,349 | Upgrade
|
Issuance of Common Stock | 5,501 | 5,515 | 30.97 | 2,583 | 132,876 | 105,736 | Upgrade
|
Repurchase of Common Stock | - | - | -15,791 | - | - | - | Upgrade
|
Other Financing Activities | 75,957 | 26,216 | -561.9 | -0 | -31,222 | -1,860 | Upgrade
|
Financing Cash Flow | 104,672 | 94,296 | 70,804 | 110,398 | 171,010 | 164,224 | Upgrade
|
Foreign Exchange Rate Adjustments | 149.26 | -72.93 | -309.07 | 4.05 | -105.81 | 47.38 | Upgrade
|
Miscellaneous Cash Flow Adjustments | -0 | - | - | - | - | - | Upgrade
|
Net Cash Flow | 21,040 | -7,385 | 27,176 | 12,872 | 24,944 | 11,743 | Upgrade
|
Free Cash Flow | -61,876 | -83,669 | -133,101 | -119,132 | 19,957 | -8,969 | Upgrade
|
Free Cash Flow Margin | -41.85% | -55.57% | -169.88% | -453.05% | 15.70% | -11.46% | Upgrade
|
Free Cash Flow Per Share | -247.53 | -354.27 | -657.66 | -687.14 | 352.97 | -196.80 | Upgrade
|
Cash Interest Paid | 130.84 | 42.76 | 10,992 | 11,339 | 875.83 | 1,156 | Upgrade
|
Cash Income Tax Paid | 664.62 | -2,128 | 3,291 | 398.92 | 294.64 | 324.68 | Upgrade
|
Levered Free Cash Flow | -11,770 | -21,656 | -145,213 | 26,095 | -48,660 | -129,818 | Upgrade
|
Unlevered Free Cash Flow | -9,192 | -21,261 | -139,022 | 39,697 | -45,391 | -124,102 | Upgrade
|
Change in Net Working Capital | -42,629 | -62,548 | 69,884 | -108,265 | 48,509 | 119,660 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.